IN ADULT PATIENTS WITH TARDIVE
DYSKINESIA (TD)

Choose INGREZZA
for
results you can see1

Not an actual patient

~70% of patients on INGREZZA® 
(valbenazine) capsules 80 mg saw
reductions in their uncontrolled 
movements at 6 weeks1,2,a

SEE STUDY RESULTS

The only once-daily treatment for TD1

See how convenient it can be for your patients to start INGREZZA.

SEE DOSING

There are many paths to INGREZZA

Discover support to help your patients start INGREZZA.

GET SUPPORT

a Post hoc analysis included patients who had a baseline and a Week 6 AIMS total score. Reduction in uncontrolled movements as assessed by ≥1-point decrease in AIMS total score.

AIMS, Abnormal Involuntary Movement Scale.

REFERENCES: 1. INGREZZA [package insert]. San Diego, CA: Neurocrine Biosciences, Inc; 2020. 2. Data on file. Neurocrine Biosciences, Inc.